Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows
₪ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2018
ILS (₪)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
ILS (₪)
Dec. 31, 2016
ILS (₪)
Cash flows from operating activities:        
Net cash used in operations (see Appendix A) ₪ (4,665) $ (1,245) ₪ (17,884) ₪ (19,357)
Net cash used in operating activities (4,665) (1,245) (17,884) (19,357)
Cash flows from investing activities:        
Restricted deposits (620) (166)
Purchase of property and equipment (2,983) (796) (447) (492)
Net cash used in investing activities (3,603) (962) (447) (492)
Cash flows from financing activities:        
Proceeds from issuance of shares, warrants and debentures, less issuance expenses 9,999 2,668 29,030 18,505
Exercise of options and warrants into shares 3,618
Loan received 210 57
Loan paid (42) (11)
Payments made for equipment on financing terms (252) (67) (253) (19)
Net cash provided by financing activities 9,915 2,647 32,395 18,486
Increase (Decrease) in cash and cash equivalents 1,647 440 14,064 (1,363)
Cash and cash equivalents at the beginning of the year 17,817 4,754 3,797 5,317
Exchange differences on cash and cash equivalents 601 160 (44) (157)
Cash and cash equivalents at the end of the year 20,065 5,354 17,817 3,797
A. Net cash used in operations:        
Comprehensive loss for the year (13,887) (3,704) (20,880) (27,893)
Adjustments for:        
Depreciation and amortization 1,472 392 1,050 864
Share-based compensation to employees and consultants 5,169 1,379 4,970 3,572
Exchange differences on cash and cash equivalents (601) (160) 44 157
Changes in fair value of financial instruments (891) (238) (35)
Exchange differences on restricted deposit (41) (11) 54 8
Total net cash used in operations (8,779) (2,342) (14,797) (23,292)
Changes in operating asset and liability items:        
Increase in trade receivables (1,579) (421) (137) (544)
Increase in inventory (2,352) (628) (213) (487)
Decrease (increase) in other receivables (including long-term receivables) 784 209 101 (95)
Increase (decrease) in trade payables (including long-term payables) (400) (107) (2,239) 2,498
Increase in accrued liabilities and other payables 370 99 379 382
Increase in contract liabilities (including long term contract liabilities) 7,309 1,950    
Increase (decrease) in royalties to the IIA (18) (5) (978) 2,181
Total changes in operating asset and liability 4,114 1,097 (3,087) 3,935
Net cash used in operations (4,665) (1,245) (17,884) (19,357)
B. Non-cash investing and financing activities        
Acquisition of fixed assets against issuance of shares and credit See Note 13(A)(1)(C). 1,678
Conversion of Debentures to pre-paid warrant 12,708 3,391
Conversion of pre-paid warrants to ordinary shares ₪ 248 $ 66